Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
15-04-20	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
15-01-30	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
14-12-05	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
14-11-20	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
14-11-18	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
14-10-28	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
14-07-31	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
14-07-25	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
14-07-17	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
14-06-24	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
14-06-19	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

15-03-04	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
15-01-28	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
14-12-06	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
14-12-01	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
14-07-29	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

14-07-17	Novartis : confirme l'objectif de croissance de ses ventes
14-07-17	Novartis : confirme l'objectif de croissance du C.A. annuel
14-06-19	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
14-04-22	S& 500 : Vague de fusions dans le domaine de la pharmacie
14-04-07	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.04%	+0.17%	+54.52%	+168.32%	1,084B
JOHNSON & JOHNSON	-1.34%	-1.26%	+66.20%	+62.83%	634B
ABBVIE INC.	-1.25%	-4.52%	+30.77%	+85.34%	447B
ROCHE HOLDING AG	+0.18%	-1.76%	+29.04%	+26.48%	330B
ASTRAZENECA PLC	-6.22%	-8.14%	+28.87%	+31.18%	295B
NOVARTIS AG	-1.27%	-2.91%	+27.42%	+44.91%	285B
NOVO NORDISK A/S	-0.93%	-3.57%	-27.74%	-39.70%	218B
AMGEN INC.	-1.28%	-2.99%	+22.41%	+61.51%	199B
GILEAD SCIENCES, INC.	-1.36%	+1.84%	+18.05%	+76.62%	169B
Average	-1.50%	+2.52%	+27.73%	+57.50%	406.65B
Weighted average by Cap.	-1.15%	+2.48%	+38.85%	+84.06%